Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use

Amikacin liposome inhalation suspension (ALIS) [Arikayce(®) Liposomal (EU); Arikayce(®) (USA)], a liposomal suspension of the aminoglycoside amikacin (590 mg) for nebulization via the Lamira(®) Nebulizer System, is available as add-on therapy for treatment-refractory Mycobacterium avium complex (MAC...

Descripción completa

Detalles Bibliográficos
Autor principal: Hoy, Sheridan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Adis Drug Q&A
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053653/
https://www.ncbi.nlm.nih.gov/pubmed/33723805
http://dx.doi.org/10.1007/s40261-021-01010-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053653/
https://www.ncbi.nlm.nih.gov/pubmed/33723805
http://dx.doi.org/10.1007/s40261-021-01010-z

Ejemplares similares